Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer
- PMID: 10602477
- DOI: 10.1038/sj.onc.1203186
Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer
Abstract
FGFRs (fibroblast growth factor receptors) are encoded by four genes (FGFR1-4). Alternative splicing results in various receptor isoforms. The FGFR2-IIIb variant is present in a wide variety of epithelia, including the bladder epithelium. Recently, we have shown that FGFR2-IIIb is downregulated in a subset of transitional cell carcinomas of the bladder, and that this downregulation is associated with a poor prognosis. We investigated possible tumour suppressive properties of FGFR2-IIIb by transfecting two human bladder tumour cell lines, J82 and T24, which have no endogenous FGFR2-IIIb expression, with FGFR2-IIIb cDNA. No stable clones expressing FGFR2-IIIb were isolated with the J82 cell line. For the T24 cell line, stable transfectants expressing FGFR2-IIIb had reduced growth in vitro and formed fewer tumours in nude mice which, in addition, grew more slowly. The potential mechanisms leading to decreased FGFR2-IIIb mRNA levels were also investigated. The 5' region of the human FGFR2 gene was isolated and found to contain a CpG island which was partially methylated in more than half the cell lines and tumours which do not express FGFR2-IIIb. No homozygous deletion was identified in any of the tumours or cell lines with reduced levels of FGFR2-IIIb. Mutational analysis of the entire coding region of FGFR2-IIIb at the transcript level was performed in 33 bladder tumours. In addition to normal FGFR2-IIIb mRNA, abnormal transcripts were detected in two tumour samples. These abnormal mRNAs resulted from exon skipping which affected the region encoding the kinase domain. Altogether, these results show that FGFR2-IIIb has tumour growth suppressive properties in bladder carcinomas and suggest possible mechanisms of FGFR2 gene inactivation.
Similar articles
-
Inhibition of human bladder tumour cell growth by fibroblast growth factor receptor 2b is independent of its kinase activity. Involvement of the carboxy-terminal region of the receptor.Oncogene. 2004 Dec 9;23(57):9201-11. doi: 10.1038/sj.onc.1208150. Oncogene. 2004. PMID: 15516981
-
Identification of a novel variant form of fibroblast growth factor receptor 3 (FGFR3 IIIb) in human colonic epithelium.Cancer Res. 1994 Oct 1;54(19):5206-11. Cancer Res. 1994. PMID: 7923141
-
Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells.Mol Cancer Res. 2004 Nov;2(11):643-52. Mol Cancer Res. 2004. PMID: 15561780
-
Epithelial cell plasticity in development and tumor progression.Cancer Metastasis Rev. 1999;18(1):31-42. doi: 10.1023/a:1006256219004. Cancer Metastasis Rev. 1999. PMID: 10505544 Review.
-
Genetic control of the cell proliferation-differentiation balance in the developing skull vault: roles of fibroblast growth factor receptor signalling pathways.Novartis Found Symp. 2001;232:102-16; discussion 116-21. doi: 10.1002/0470846658.ch8. Novartis Found Symp. 2001. PMID: 11277075 Review.
Cited by
-
Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells.Am J Pathol. 2007 May;170(5):1618-28. doi: 10.2353/ajpath.2007.061111. Am J Pathol. 2007. PMID: 17456767 Free PMC article.
-
Loss of Fibroblast Growth Factor Receptor 2 (FGFR2) Leads to Defective Bladder Urothelial Regeneration after Cyclophosphamide Injury.Am J Pathol. 2021 Apr;191(4):631-651. doi: 10.1016/j.ajpath.2020.12.011. Epub 2020 Dec 30. Am J Pathol. 2021. PMID: 33385344 Free PMC article.
-
Alternative splicing in endothelial cells: novel therapeutic opportunities in cancer angiogenesis.J Exp Clin Cancer Res. 2020 Dec 7;39(1):275. doi: 10.1186/s13046-020-01753-1. J Exp Clin Cancer Res. 2020. PMID: 33287867 Free PMC article. Review.
-
Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease.Am J Pathol. 2004 Oct;165(4):1233-41. doi: 10.1016/S0002-9440(10)63383-4. Am J Pathol. 2004. PMID: 15466389 Free PMC article.
-
Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth.Am J Pathol. 2010 Mar;176(3):1433-42. doi: 10.2353/ajpath.2010.090356. Epub 2010 Jan 21. Am J Pathol. 2010. PMID: 20093481 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous